|
1-O-eicosanoyl-2-O-dodecanoylphosphatidylcholine
|
C089667 |
|
|
1-O-decanoyl-2-O-docosanoylphosphatidylcholine
|
C089668 |
|
|
1-(3-sulfonatopropyl)-4-(beta-(2-(di-n-octylamino)-6-naphthyl)vinyl)pyridinium betaine
|
C089669 |
|
|
2-chloro-3,3-dimethylacrolein
|
C089660 |
|
|
progesterone 11-hemisuccinate-(2-iodohistamine)
|
C089662 |
|
|
bis(3,5-dibromosalicyl)sebacate
|
C089663 |
|
|
N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine
|
C089665 |
|
|
quinolactacin B2
|
C521724 |
|
|
dicitrinin A
|
C521725 |
|
|
N,N-dimethylsulfamoyl chloride
|
C521726 |
|
|
2-propanesulfonyl chloride
|
C521727 |
|
|
Shc4 protein, mouse
|
C521729 |
|
|
imidazolium tetrachlorobis(1H-imidazole)ruthenate(III)
|
C521720 |
|
|
1,2-bis(di(benzo-15-crown-5)phosphino)ethane
|
C521721 |
|
|
Extracellular Traps
|
D065206 |
[Extracellular structure primarily composed of CHROMATIN and associated PROTEASES.
] |
|
1,2-bis(bis(3,4-dimethoxyphenyl)phosphino)ethane
|
C521722 |
|
|
Middle East Respiratory Syndrome Coronavirus
|
D065207 |
[A coronavirus first reported in the summer of 2012 in a pneumonia patient in SAUDI ARABIA. It is related to SARS VIRUS. MERS-CoV has an estimated incubation period of 12 days and symptoms include renal failure and severe acute pneumonia with often fatal outcome.
] |
|
glyceraldehyde butane-2,3-diacetal
|
C521723 |
|
|
pingchuan yiqi
|
C521735 |
|
|
ning shen ling
|
C521736 |
|
